News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
326,689 Results
Type
Article (23092)
Company Profile (134)
Press Release (303463)
Multimedia
Podcasts (9)
Webinars (7)
Section
Business (94961)
Career Advice (642)
Deals (21196)
Drug Delivery (46)
Drug Development (41010)
Employer Resources (68)
FDA (7320)
Job Trends (8041)
News (162632)
Policy (12562)
Tag
Academia (1711)
Academic (1)
Accelerated approval (3)
Adcomms (10)
Allergies (33)
Alliances (25404)
ALS (64)
Alzheimer's disease (767)
Antibody-drug conjugate (ADC) (90)
Approvals (7351)
Artificial intelligence (199)
Autoimmune disease (17)
Automation (13)
Bankruptcy (172)
Best Places to Work (7182)
BIOSECURE Act (7)
Biosimilars (30)
Biotechnology (111)
Bladder cancer (52)
Brain cancer (19)
Breast cancer (191)
Cancer (1587)
Cardiovascular disease (127)
Career advice (565)
Career pathing (20)
CAR-T (125)
Cell therapy (353)
Cervical cancer (11)
Clinical research (32934)
Collaboration (659)
Company closure (2)
Compensation (227)
Complete response letters (8)
COVID-19 (1375)
CRISPR (40)
C-suite (203)
Cystic fibrosis (84)
Data (1615)
Decentralized trials (1)
Depression (25)
Diabetes (132)
Diagnostics (3979)
Digital health (13)
Diversity (2)
Diversity, equity & inclusion (20)
Drug discovery (84)
Drug pricing (27)
Drug shortages (6)
Duchenne muscular dystrophy (76)
Earnings (35692)
Editorial (23)
Employer branding (8)
Employer resources (62)
Events (44103)
Executive appointments (604)
FDA (8248)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (565)
Gene editing (105)
Generative AI (18)
Gene therapy (289)
GLP-1 (290)
Government (2010)
Grass and pollen (2)
Guidances (136)
Healthcare (10450)
Huntington's disease (13)
IgA nephropathy (22)
Immunology and inflammation (69)
Indications (17)
Infectious disease (1465)
Inflammatory bowel disease (92)
Inflation Reduction Act (2)
Influenza (35)
Intellectual property (58)
Interviews (94)
IPO (8398)
IRA (10)
Job creations (1248)
Job search strategy (476)
Kidney cancer (5)
Labor market (11)
Layoffs (230)
Leadership (13)
Legal (2045)
Liver cancer (37)
Lung cancer (198)
Lymphoma (117)
Machine learning (4)
Management (21)
Manufacturing (197)
MASH (48)
Medical device (6478)
Medtech (6480)
Mergers & acquisitions (13292)
Metabolic disorders (339)
Multiple sclerosis (66)
NASH (11)
Neurodegenerative disease (68)
Neuropsychiatric disorders (15)
Neuroscience (1150)
NextGen: Class of 2025 (3283)
Non-profit (2659)
Now hiring (9)
Obesity (154)
Opinion (133)
Ovarian cancer (84)
Pain (57)
Pancreatic cancer (48)
Parkinson's disease (100)
Partnered (12)
Patents (119)
Patient recruitment (67)
Peanut (14)
People (30462)
Pharmaceutical (23)
Pharmacy benefit managers (7)
Phase I (11329)
Phase II (14663)
Phase III (10687)
Pipeline (994)
Policy (56)
Postmarket research (1000)
Preclinical (4924)
Press Release (49)
Prostate cancer (60)
Psychedelics (10)
Radiopharmaceuticals (132)
Rare diseases (320)
Real estate (2245)
Recruiting (27)
Regulatory (9734)
Reports (21)
Research institute (1757)
Resumes & cover letters (91)
Rett syndrome (6)
RNA editing (5)
RSV (14)
Schizophrenia (47)
Series A (102)
Series B (69)
Service/supplier (4)
Sickle cell disease (49)
Special edition (6)
Spinal muscular atrophy (140)
Sponsored (19)
Startups (1943)
State (2)
Stomach cancer (3)
Supply chain (31)
Tariffs (15)
The Weekly (9)
Vaccines (372)
Venture capitalists (24)
Weight loss (69)
Women's health (14)
Worklife (10)
Date
Today (91)
Last 7 days (665)
Last 30 days (2060)
Last 365 days (20428)
2025 (7759)
2024 (21745)
2023 (24144)
2022 (30413)
2021 (32773)
2020 (30467)
2019 (24739)
2018 (18321)
2017 (16371)
2016 (14925)
2015 (16849)
2014 (11786)
2013 (9625)
2012 (9536)
2011 (9806)
2010 (8609)
Location
Africa (340)
Alabama (24)
Alaska (3)
Arizona (77)
Arkansas (6)
Asia (18558)
Australia (3059)
California (4092)
Canada (1084)
China (317)
Colorado (147)
Connecticut (191)
Delaware (108)
Europe (45940)
Florida (518)
Georgia (106)
Idaho (26)
Illinois (274)
India (14)
Indiana (228)
Iowa (6)
Japan (129)
Kansas (32)
Kentucky (13)
Louisiana (10)
Maine (19)
Maryland (536)
Massachusetts (3203)
Michigan (127)
Minnesota (176)
Mississippi (1)
Missouri (51)
Montana (11)
Nebraska (11)
Nevada (37)
New Hampshire (37)
New Jersey (1100)
New Mexico (17)
New York (1148)
North Carolina (627)
North Dakota (9)
Northern California (1824)
Ohio (107)
Oklahoma (11)
Oregon (17)
Pennsylvania (883)
Puerto Rico (9)
Rhode Island (16)
South America (517)
South Carolina (13)
South Dakota (1)
Southern California (1453)
Tennessee (47)
Texas (645)
United States (14890)
Utah (131)
Virginia (108)
Washington D.C. (33)
Washington State (372)
West Virginia (2)
Wisconsin (38)
326,689 Results for "trans ova genetics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Precigen Completes Sale of Non-Healthcare Subsidiary Trans Ova Genetics
Precigen, Inc. today announced that the Company has completed the sale of its wholly-owned non-healthcare subsidiary, Trans Ova Genetics, L.C.
August 22, 2022
·
3 min read
Press Releases
U.S. Patent Office Issues New Patent to RenovoRx for Novel Trans-Arterial Micro-Profusion (TAMP™) Therapy Platform
May 7, 2025
·
10 min read
Deals
Precigen Enters into Agreement to Divest Non-Healthcare Subsidiary Trans Ova Genetics
Precigen enters into agreement to sell wholly-owned subsidiary Trans Ova Genetics to URUS for $170 million in upfront cash and up to $10 million earn-out over two years; close expected in Q3 2022.
July 5, 2022
·
4 min read
Press Releases
Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND™ Trans-Septal System
March 13, 2025
·
3 min read
Press Releases
ViGeneron Announces FDA Clearance of IND for Novel mRNA Trans-Splicing Gene Therapy VG801 to Treat Stargardt Disease and Other ABCA4-Linked Retinal Dystrophies
December 18, 2024
·
4 min read
Press Releases
Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy
May 6, 2025
·
5 min read
Gene therapy
Regeneron’s Gene Therapy Restores Hearing in Patients with Rare Genetic Condition
The treatment, called DB-OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic deafness.
February 24, 2025
·
4 min read
·
Dan Samorodnitsky
Press Releases
Myriad Genetics Announces Senior Leadership Transition
February 25, 2025
·
4 min read
Press Releases
Baylor Genetics Joins Child Neurology Society as Official Genetic Testing Partner
April 29, 2025
·
3 min read
Press Releases
Opus Genetics Files Definitive Proxy Statement and Sends Letter to Stockholders Highlighting the Company’s Transformation and Progress
April 7, 2025
·
12 min read
1 of 32,669
Next
